Barbara Paldus is the founder of biotech company Codex Labs and an expert on all things skincare, skin health and skin ...

VRG Therapeutics reaches monthly dosing for its lead program targeting Kv1.3 for the treatment of atopic dermatitis and other chronic inflammatory diseases.

The global canine atopic dermatitis treatment market is projected to witness substantial growth over the next decade, with a ...

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

Dr. Holman says this staphylococcus bacteria is the most common cause of infection in patients with atopic dermatitis (also ...

Incyte Biosciences Canada today announced that Health Canada has granted a Notice of Compliance for OPZELURA® (ruxolitinib ...

Eczema is a prevalent skin condition that affects millions of people, characterized by red, dry and itchy patches on the skin ...

A global team of researchers at the Max Planck Institute of Biochemistry has made a groundbreaking discovery that saves the lives of patients suffering from toxic epidermal necrolysis.

Roflumilast cream 0.15% is a safe and efficacious treatment for mild to moderate atopic dermatitis among children, adolescents, and adults.

Full session details can be accessed on the ACAAI website. The poster will be available on the publications page of the Apogee website on October 24.

Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on ...

Oat-based moisturizers come packed with a host of unexpected bonuses for those trying to manage symptoms of atopic dermatitis ...